LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Erie Indemnity Company (ERIE) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a ERIE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders are trading both ways.
Buys/Adds (2)
Millennium
$27.8M
added
JPMorgan Chase
$7.8M
added
Buys (1)
Vorsheck Elizabeth A
$1.4M
bought
Sells (1)
Dabreo Anthony
$101K
sold
No tracked top-trader positions in ERIE right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$3.35 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $3.45 / $3.35Alpha Vantage | +2.99% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 23, 2026 | $2.90 / $3.06Alpha Vantage | -5.23% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 23, 2026 | $2.76 / $3.09Alpha Vantage | -10.64% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $3.49 / $3.37Alpha Vantage | +3.56% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $3.34 / $3.55Alpha Vantage | -5.92% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $2.65 / $3.19Alpha Vantage | -16.93% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | $2.91 / $2.90Alpha Vantage | +0.28% in line | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | $3.02 / $2.99Alpha Vantage | +1.00% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 16, 2026
EPS expected
$3.41 to $3.41
Revenue expected
1 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.07B | $951.2M | $1.01B | $1.09B |
| Cost of what it sold | $876.2M | $812.5M | $865.1M | $885.7M |
| Gross profit | $191.2M | $138.7M | $146.9M | $204.1M |
| What it spent | ||||
| Sales and admin | $215.7M | $19.3M | $19.5M | $19.6M |
| Other operating costs | -$234.8M | -$38.3M | -$38.6M | — |
| Total operating expenses | -$19.1M | -$19.0M | -$19.1M | $19.6M |
| What was left | ||||
| Operating profit | $210.3M | $157.7M | $166.0M | $204.1M |
| Profit before tax | $232.8M | $82.3M | $190.3M | $228.1M |
| Tax | $49.9M | $19.0M | $39.9M | $47.8M |
| Net profit | $182.9M | $63.4M | $150.5M | $180.3M |
| EBITDA | $251.2M | $101.5M | $210.3M | $228.1M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
